Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Internal validation & live display
Insurers and partners see a safer profile
Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Society of ActuariesCAS
Proud contributor to the Society of Actuaries.
Company Logo
SBG
Boost Score +25 with badge (5 left)
749
/1000
Moderate
Verified Badge
Boost Arrows
774
/1000
Fair
SIRION BIOTECH GmbH (Revvity Gene Delivery)

SIRION BIOTECH GmbH (Revvity Gene Delivery) Vendor Cyber Rating & Cyber Score

sirion-biotech.com

Viral Vector Services from Vector Engineering and Manufacturing to Cell and Gene Therapy Development Revvity Gene Delivery (formerly SIRION Biotech) supports your cell and gene therapy development process ̶ offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. Whether you need small scale viral production or full scale viral vector optimization and manufacture, our expert team has you covered. For additional information, please visit www.sirion-biotech.com.


SBG A.I CyberSecurity Scoring

Scoring History
SBG
Company Information
Website:http://www.sirion-biotech.com
Employees number:25
Number of followers:3,920
NAICS:541714
Industry Type:Biotechnology Research
Homepage:sirion-biotech.com
SBG Risk Score (AI oriented)
Between 700 and 749
logo
SBGBiotechnology Research
Updated:
26/02/2026
749/1000
Moderate
Ba
AaaAaABaaBaBCaaCaC
Powered by our proprietary A.I cyber incident model
✖ Insurance prefers TPRM score to calculate premium
SBG Global Score (TPRM)
xxxx
logo
SBGBiotechnology Research
•••
Score locked
Instant access to detailed risk factors
Vulnerabilities
Benchmark vs. industry & size peers
Findings
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…